Systematic review with meta-analysis: The effect of tobacco smoking on the natural history of ulcerative colitis

Alimentary Pharmacology and Therapeutics

Volumn 44, Issue 2, 2016, Pages 117-126

  To, N ^a,b   Ford, A C ^a,b   Gracie, D J ^a,b  

^a ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

^b UNIVERSITY OF LEEDS   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COLON RESECTION; DISEASE COURSE; DISEASE EXACERBATION; HUMAN; ILEITIS; ILEOANAL ANASTOMOSIS; OBSERVATIONAL STUDY; PANPROCTOCOLECTOMY; PATIENT CARE; PRIORITY JOURNAL; SMOKING; SMOKING CESSATION; SYSTEMATIC REVIEW; ULCERATIVE COLITIS; ADVERSE EFFECTS; ANAL CANAL; COLITIS, ULCERATIVE; COLOSTOMY BAG; META ANALYSIS; POUCHITIS;

ANAL CANAL; COLECTOMY; COLITIS, ULCERATIVE; COLONIC POUCHES; HUMANS; POUCHITIS; SMOKING;

EID: 84970963281     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13663     Document Type: Article

References (60)

1. Ford AC, Moayyedi P, Hanauer SB,. Ulcerative colitis. BMJ 2013; 346: f432.
2. Danese S, Fiocchi C,. Ulcerative colitis. N Engl J Med 2011; 365: 1713-25.
3. Cohen RD, Yu AP, Wu EQ, Xie J, Mulani PM, Chao J,. Systematic review: the costs of ulcerative colitis in Western countries. Aliment Pharmacol Ther 2010; 31: 693-707.
4. Singh UP, Singh NP, Murphy EA, et al,. Chemokine and cytokine levels in inflammatory bowel disease patients. Cytokine 2016; 77: 44-9.
5. Rogler G, Vavricka S,. Exposome in IBD: recent insights in environmental factors that influence the onset and course of IBD. Inflamm Bowel Dis 2015; 21: 400-8.
6. Anderson CA, Boucher G, Lees CW, et al,. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47. Nat Genet 2011; 43: 246-52.
7. Harries AD, Baird A, Rhodes J,. Non-smoking: a feature of ulcerative colitis. Br Med J (Clin Res Ed) 1982; 284: 706.
8. Calkins BM,. A meta-analysis of the role of smoking in inflammatory bowel disease. Dig Dis Sci 1989; 34: 1841-54.
9. Lunney PC, Leong RW,. Review article: ulcerative colitis, smoking and nicotine therapy. Aliment Pharmacol Ther 2012; 36: 997-1008.
10. Beaugerie L, Massot N, Carbonnel F, Cattan S, Gendre JP, Cosnes J,. Impact of cessation of smoking on the course of ulcerative colitis. Am J Gastroenterol 2001; 96: 2113-6.
11. Lindberg E, Tysk C, Andersson K, Järnerot G,. Smoking and inflammatory bowel disease. A case control study. Gut 1988; 29: 352-7.
12. Höie O, Wolters F, Riis L, et al,. Ulcerative colitis: patient characteristics may predict 10-yr disease recurrence in a European-wide population-based cohort. Am J Gastroenterol 2007; 102: 1692-701.
13. Calabrese E, Yanai H, Shuster D, Rubin DT, Hanauer SB,. Low-dose smoking resumption in ex-smokers with refractory ulcerative colitis. J Crohns Colitis 2012; 6: 756-62.
14. Lunney PC, Kariyawasam VC, Wang RR, et al,. Smoking prevalence and its influence on disease course and surgery in Crohn's disease and ulcerative colitis. Aliment Pharmacol Ther 2015; 42: 61-70.
15. Joelsson M, Benoni C, Oresland T,. Does smoking influence the risk of pouchitis following ileal pouch anal anastomosis for ulcerative colitis? Scand J Gastroenterol 2006; 41: 929-33.
16. Merrett MN, Mortensen N, Kettlewell M, Jewell DO,. Smoking may prevent pouchitis in patients with restorative proctocolectomy for ulcerative colitis. Gut 1996; 38: 362-4.
17. Wells GA, Shea B, O'Connell D, et al,. The Newcastle-Ottawa Scale (NOS) for assessing the quality of non-randomised studies in meta-analyses. Available at: http://www.ohri.ca/programs/clinical-epidemiology/oxford.asp (accessed online 9th Feb 2016).
18. Higgins JP, Thompson SG, Deeks JJ, Altman DG,. Measuring inconsistency in meta-analyses. BMJ 2003; 327: 557-60.
19. DerSimonian R, Laird N,. Meta-analysis in clinical trials. Control Clin Trials 1986; 7: 177-88.
20. Egger M, Davey Smith G, Schneider M, Minder C,. Bias in meta-analysis detected by a simple, graphical test. BMJ 1997; 315: 629-34.
21. Sterne JA, Sutton AJ, Ioannidis JP, et al,. Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials. BMJ 2011; 343: d4002.
22. Aldhous MC, Drummond HE, Anderson N, et al,. Smoking habit and load influence age at diagnosis and disease extent in ulcerative colitis. Am J Gastroenterol 2007; 102: 589-97.
23. Russel MG, Volovics A, Schoon EJ, et al,. Inflammatory bowel disease: is there any relation between smoking status and disease presentation? European Collaborative IBD Study Group. Inflamm Bowel Dis 1998; 4: 182-6.
24. Hoie O, Wolters FL, Riis L, et al,. Low colectomy rates in ulcerative colitis in an unselected European cohort followed for 10 years. Gastroenterology 2007; 132: 507-15.
25. Haritunians T, Taylor KD, Targan SR, et al,. Genetic predictors of medically refractory ulcerative colitis. Inflamm Bowel Dis 2010; 16: 1830-40.
26. Levenstein S, Prantera C, Varvo V, et al,. Stress and exacerbation in ulcerative colitis: a prospective study of patients enrolled in remission. Am J Gastroenterol 2000; 95: 1213-20.
27. Bitton A, Peppercorn MA, Antonioli DA, et al,. Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis. Gastroenterology 2001; 120: 13-20.
28. Hosseini SV, Safarpour AR, Taghavi SA,. Developing a novel risk-scoring system for predicting relapse in patients with ulcerative colitis: a prospective cohort study. Pak J Med Sci 2015; 31: 1511-6.
29. Meucci G, Vecchi M, Astegiano M, et al,. The natural history of ulcerative proctitis: a multicenter, retrospective study. Gruppo di Studio per le Malattie Infiammatorie Intestinali (GSMII). Am J Gastroenterol 2000; 95: 469-73.
30. Waterman M, Knight J, Dinani A, et al,. Predictors of outcome in ulcerative colitis. Inflamm Bowel Dis 2015; 21: 2097-105.
31. Chatzicostas C, Roussomoustakaki M, Potamianos S, et al,. Factors associated with disease evolution in Greek patients with inflammatory bowel disease. BMC Gastroenterol 2006; 6: 21.
32. Anzai H, Hata K, Kishikawa J, et al,. Clinical pattern and progression of ulcerative proctitis in the Japanese population: a retrospective study of incidence and risk factors influencing progression. Colorectal Dis 2016; 18: O97-102.
33. Kuisma J, Järvinen H, Kahri A, Färkkilä M,. Factors associated with disease activity of pouchitis after surgery for ulcerative colitis. Scand J Gastroenterol 2004; 39: 544-8.
34. Stählberg D, Gullberg K, Liljeqvist L, Hellers G, Löfberg R,. Pouchitis following pelvic pouch operation for ulcerative colitis. Incidence, cumulative risk, and risk factors. Dis Colon Rectum 1996; 39: 1012-8.
35. Fuller-Thomson E, Sulman J,. Depression and inflammatory bowel disease: findings from two nationally representative Canadian surveys. Inflamm Bowel Dis 2006; 12: 697-707.
36. Fuller-Thomson E, Lateef R, Sulman J,. Robust association between inflammatory bowel disease and generalized anxiety disorder: findings from a Nationally Representative Canadian Study. Inflamm Bowel Dis 2015; 21: 2341-8.
37. Mittermaier C, Dejaco C, Waldhoer T, et al,. Impact of depressive mood on relapse in patients with inflammatory bowel disease: a prospective 18-month follow-up study. Psychosom Med 2004; 66: 79-84.
38. Kouvonen A, Kivimaki M, Virtanen M, Pentti J, Vahtera J,. Work stress, smoking status, and smoking intensity: an observational study of 46,190 employees. J Epidemiol Community Health 2005; 59: 63-9.
39. Dignass A, Eliakim R, Magro F, et al,. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 1: definitions and diagnosis. J Crohns Colitis 2012; 6: 965-90.
40. Benoni C, Nilsson A,. Smoking habits in patients with inflammatory bowel disease. Scand J Gastroenterol 1984; 19: 824-30.
41. Thomas GA, Rhodes J, Green JT,. Inflammatory bowel disease and smoking - A review. Am J Gastroenterol 1998; 93: 144-9.
42. Dias CC, Rodrigues PP, da Costa-Pereira A, Magro F,. Clinical predictors of colectomy in patients with ulcerative colitis: systematic review and meta-analysis of cohort studies. J Crohns Colitis 2015; 9: 156-63.
43. Ho GT, Mowat C, Goddard CJ, et al,. Predicting the outcome of severe ulcerative colitis: development of a novel risk score to aid early selection of patients for second-line medical therapy or surgery. Aliment Pharmacol Ther 2004; 19: 1079-87.
44. Ho GT, Chiam P, Drummond H, Loane J, Arnott ID, Satsangi J,. The efficacy of corticosteroid therapy in inflammatory bowel disease: analysis of a 5-year UK inception cohort. Aliment Pharmacol Ther 2006; 24: 319-30.
45. Ananthakrishnan AN, Issa M, Beaulieu DB, et al,. History of medical hospitalization predicts future need for colectomy in patients with ulcerative colitis. Inflamm Bowel Dis 2009; 15: 176-81.
46. Solberg IC, Lygren I, Jahnsen J, et al,. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study). Scand J Gastroenterol 2009; 44: 431-40.
47. Rudra T, Motley R, Rhodes J,. Does smoking improve colitis? Scand J Gastroenterol Suppl. 1989; 170: 61-3; discussion 6-8.
48. Green JT, Rhodes J, Ragunath K, et al,. Clinical status of ulcerative colitis in patients who smoke. Am J Gastroenterol 1998; 93: 1463-7.
49. McGrath J, McDonald JW, Macdonald JK,. Transdermal nicotine for induction of remission in ulcerative colitis. Cochrane Database Syst Rev 2004 (4): CD004722.
50. Nikfar S, Ehteshami-Ashar S, Rahimi R, Abdollahi M,. Systematic review and meta-analysis of the efficacy and tolerability of nicotine preparations in active ulcerative colitis. Clin Ther 2010; 32: 2304-15.
51. Thomas GA, Rhodes J, Ragunath K, et al,. Transdermal nicotine compared with oral prednisolone therapy for active ulcerative colitis. Eur J Gastroenterol Hepatol 1996; 8: 769-76.
52. Thomas GA, Rhodes J, Mani V, et al,. Transdermal nicotine as maintenance therapy for ulcerative colitis. N Engl J Med 1995; 332: 988-92.
53. Ockene IS, Miller NH,. Cigarette smoking, cardiovascular disease, and stroke: a statement for healthcare professionals from the American Heart Association. American Heart Association Task Force on Risk Reduction. Circulation 1997; 96: 3243-7.
54. Forey BA, Thornton AJ, Lee PN,. Systematic review with meta-analysis of the epidemiological evidence relating smoking to COPD, chronic bronchitis and emphysema. BMC Pulm Med 2011; 11: 36.
55. Doll R, Peto R, Wheatley K, Gray R, Sutherland I,. Mortality in relation to smoking: 40 years' observations on male British doctors. BMJ 1994; 309: 901-11.
56. Gandini S, Botteri E, Iodice S, et al,. Tobacco smoking and cancer: a meta-analysis. Int J Cancer 2008; 122: 155-64.
57. Doll R, Peto R, Boreham J, Sutherland I,. Mortality in relation to smoking: 50 years' observations on male British doctors. BMJ 2004; 328: 1519.
58. De Bie C, Ballet V, Hendriks N, et al,. Smoking behaviour and knowledge of the health effects of smoking in patients with inflammatory bowel disease. Aliment Pharmacol Ther 2015; 42: 1294-302.
59. To N, Gracie DJ, Ford AC,. Systematic review with meta-analysis: the adverse effects of tobacco smoking on the natural history of Crohn's disease. Aliment Pharmacol Ther 2016; 43: 549-61.
60. Dignass A, Lindsay JO, Sturm A, et al,. Second European evidence-based consensus on the diagnosis and management of ulcerative colitis part 2: current management. J Crohns Colitis 2012; 6: 991-1030.